SEC Filing Summary: AspenBio, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by AspenBio, Inc. on December 6, 2004. The registrant is incorporated in Colorado with principal executive offices in Castle Rock, CO. The filing addresses a specific disclosure event under Item 7.01 (Regulation FD Disclosure) regarding an unauthorized or unreliable third-party publication.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
There are no material changes to financial operations reported. The material event is the Registrant's discovery on December 4, 2004, that an interview titled "Company Interview Excerpt Roger Hurst - AspenBio Inc" was published by The Wall Street Transcript on or about October 29, 2004.
Management Commentary and Risks
- Unreliable Information: Management explicitly states that the information contained in the October 29, 2004, interview should not be relied upon by the marketplace.
- Official Disclosure Channel: Investors are directed to rely solely on publicly filed and disclosed information from the Registrant.
- Future Action: The Registrant indicated it would provide additional disclosures regarding this matter shortly.
Key Facts for Investor Verification
- Verify that no financial or operational data from the October 29, 2004, Wall Street Transcript interview is used in valuation models.
- Monitor subsequent filings for the "additional disclosures" promised by management regarding the interview.
- Confirm that the company name in the metadata (Riot Platforms, Inc.) is incorrect; the filing is for AspenBio, Inc.